Patrik Jeanmonod sold $21k of CTKB
Chief Financial Officer at Cytek Biosciences, Inc.. 3,000 shares at an average of $6.94, traded Nov 24, 2023, filed Nov 27, 2023.
Score components
- +22RoleCFO
- 0Trade size$21k at market
- 0Share of holdings soldSold 3.0% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +38.7%, 3m +29.0%, 6m -12.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-23-056733, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2023 | SOpen-market sale Common Stock10b5-1 | -3,000 | $6.94 | $21k | 96,400 | Nov 27, 2023 |
Related signals
Other insiders at Cytek Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | CTKBbuy Cytek Biosciences, Inc. | William D. McCombe Chief Financial Officer | $97k 35,000 shares | +169% | |
| 5Weak | Cytek Biosciences, Inc. | Ming Yan CHIEF TECHNOLOGY OFFICER | $117k 20,000 shares | -0% | |
| 0Weak | Cytek Biosciences, Inc. | Ming Yan CHIEF TECHNOLOGY OFFICER | $13k 1,900 shares | -0% | |
| 8Weak | Cytek Biosciences, Inc. | Ming Yan CHIEF TECHNOLOGY OFFICER | $270k 40,000 shares | -1% | |
| 15Weak | Cytek Biosciences, Inc. | Patrik Jeanmonod Chief Financial Officer | $29k 3,000 shares | -3% | |
| 15Weak | Cytek Biosciences, Inc. | Ming Yan Chief Technology Officer | $189k 20,000 shares | -0% | |
| 5Weak | Cytek Biosciences, Inc. | Ming Yan Chief Technology Officer | $121k 20,000 shares | -0% | |
| 29Weak | Cytek Biosciences, Inc. | Wenbin Jiang President and CEO | $87k 20,000 shares | -0% | |
| 17Weak | Cytek Biosciences, Inc. | Patrik Jeanmonod Chief Financial Officer | $14k 3,000 shares | -3% | |
| 20Weak | Cytek Biosciences, Inc. | Ming Yan Chief Technology Officer | $96k 20,000 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.